Clinical applications of recombinant human growth hormone in adults

Bibliography

• GROWTH HORMONE RESEARCH SOCIETY: Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society workshop on adult growth hormone deficiency. J. Clin. Endocrinol. Metab. (1998) 48:109–115.
   Google Scholar
• ••Present recommendations on the diagnosis and treatment ofadult GHD syndrome.
   Google Scholar
• CORCORAN C, GRINSPOON S: Treatments for wasting in patients with the acquired immunodeficiency syndrome. New Engl. J. Merl. (1999) 340:1740–1750.
   Google Scholar
• ••Excellent review of anabolic treatments for patients withAIDS wasting.
   Google Scholar
• WALLYMAHMED ME, FOY P, SHAW D, HUTCHEON R, EDWARDS RH, MACFARLANE IA: Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin. Endocrinol. (1997) 47:439–446.
   PubMed Web of Science ®Google Scholar
• •Prospective study of rhGH replacement therapy in adult GHD.
   Google Scholar
• JOHANNSSON G, GRIMBY G, SUNNERHAGEN KS,BENGTSSON BA: Two years of growth hormone (G11) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. J. Clin. Endocrinol. Metab. (1997) 82:2877–2884.
   PubMedGoogle Scholar
• SHALET SM, TOOGOOD A, RAHIM A, BRENNAN BM: The diagnosis of growth hormone deficiency in children and adults. Endocr. Rev. (1998) 19:203–223.
   PubMed Web of Science ®Google Scholar
• ••A thorough review of clinical and biochemical approachesto the diagnosis of GHD syndrome.
   Google Scholar
• MANSON JMCK, WILMORE DW: Positive nitrogenbalance with human growth hormone and hypocaloric intravenous feeding. Surgery (1986) 100:188–197.
   PubMedGoogle Scholar
• CARROLL PV, CHRIST ER, BENGTSSON BA et al: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Endocrinol. Metab. (1998) 83:382–395.
   Google Scholar
• ••An excellent review of GHD in adults and the effects of GHreplacement.
   Google Scholar
• RUSSELL-JONES DL, BOWES SB, REES SE et al.: Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults. Am. Physiol (1998) 274:E1050–1056.
   Google Scholar
• ••A randomised study of anabolic effect of GH, bodycomposition and protein metabolism in GHD adults.
   Google Scholar
• JENSEN MB, KISSMEYER NIELSEN P, LAURBERG S: Perioperative growth hormone treatment increases nitrogen and fluid balance and results in short-term and long-term conservation of lean tissue mass. Am. J. Clin. Nutr. (1998) 68:840–846.
   PubMed Web of Science ®Google Scholar
• AL SHOUMER KA, GRAY R, ANYAOKU V et al: Effects of four years' treatment with biosynthetic human growth hormone (GI-1) on glucose homeostasis, insulin secretion and lipid metabolism in Gil deficient adults. Clin. Endocrinol. (1998) 48:795–802.
   PubMed Web of Science ®Google Scholar
• BESHYAH SA, JOHNSTON DG: Cardiovascular disease and risk factors in adults with hypopituitarism. Endocrinol. (1999) 50:1–15.
   Google Scholar
• ••A recent review of epidemiological and experimental dataon cardiovascular morbidity and mortality in adult hypopituitarism.
   Google Scholar
• OHLSSON C, BENGTSSON B, ISAKSSON OGP, ANDREASSEN TT, SLOOTWEG MC: Growth hormone and bone. Endocr. Rev. (1998) 19:55–79.
   PubMed Web of Science ®Google Scholar
• ••A thorough review of the effects of GH on bone both inanimals and humans.
   Google Scholar
• ROSEN T, WILHELMSEN L, LANDIN-WILHELMSEN K, LAPPAS G, BENGTSSON BA: Increased fracture frequency in adult patients with hypopituitarism and Gil deficiency. Eur. J. Endocrinol. (1997) 137:240–245.
   PubMed Web of Science ®Google Scholar
• •Comparative study of fracture rate in patients with adult-onset GHD.
   Google Scholar
• RAHIM A, HOLMES SJ, ADAMS JE, SHALET SM: Long-term change in the bone mineral density of adults with adult onset growth hormone (GI-1) deficiency in response to short or long-term Gil replacement therapy. Clin. Endocrinol. (1998) 48(4):463–469.
   PubMedGoogle Scholar
• •Evaluation of long-term impact on BMD after a short course of GH replacement in GHD adults.
   Google Scholar
• CUOCOLO A, NICOLAI E, COLAO A et al.: Improved left ventricular function after growth hormone replace-ment in patients with hypopituitarism: assessment with radionuclide angiography. Eur. J. Nucl. Med. (1996) 23:390–394.
   PubMedGoogle Scholar
• DUNNE FP, ELLIOT P, GAMMOGE MD et al: Cardiovas-cular function and glucocorticoid replacement in patients with hypopituitarism. Gun. Endocrinol. (1995) 43:623–629.
   Google Scholar
• MOLLER J, JORGENSEN JO, MOLLER N, CHRISTIANSEN JS, WEEKE J: Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism (1992) 41:728–731.
   PubMed Web of Science ®Google Scholar
• JORGENSEN JO, MOLLER J, SKAKKEBAEK NE, WEEKE J, CHRISTIANSEN JS: Thyroid function during growth hormone therapy. Horm. Res. (1992) 38\(Suppl. 1):63–67.
   Google Scholar
• FELD S, HIRSCHBERG R: Growth hormone, the insulin-like growth factor system, and the kidney. Endocr. Rev. (1996) 17:423–480.
   PubMed Web of Science ®Google Scholar
• ••An excellent review of GH and the kidney.
   Google Scholar
• JENKINS RC, ROSS RJM: Growth hormone therapy for protein catabolism. Quart. J. Med. (1996) 89:813–819.
   Google Scholar
• ••A detailed review of GH therapy in the catabolic patient.
   Google Scholar
• TRITOS NA, MANTZOROS CS: Recombinant human growth hormone: old and novel uses. Am. J. Med. (1998) 105:44–57.
   PubMedGoogle Scholar
• ••A thorough review of paediatric and adult uses of rhGH.
   Google Scholar
• CUNEO RC, JUDD S, WALLACE JD et al. The Australian multicenter trial of growth hormone (Gil) treatment in GH-deficient adults. J. Clin. Endocrinol. Metab. (1998) 83:107–116.
   PubMed Web of Science ®Google Scholar
• ••Results of an Australian multicentre, randomised, double-blind, placebo-controlled trial of the effects of rhGH in adults with GHD.
   Google Scholar
• DE BOER H, VAN DER VEEN E: Guidelines for optimizing growth hormone replacement therapy in adults. Horm. Res. (1997) 48\(Suppl. 5):21–30.
   Google Scholar
• •Review of rhGH replacement therapy in adults with GHD.
   Google Scholar
• MULLIGAN K, GRUNFELD C, HELLERSTEIN MK, NEESE RA,SCHAMBELAN M: Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J. Gun. Endocrinol. Metab. (1993) 77:956–962.
   PubMed Web of Science ®Google Scholar
• KRENTZ AJ, KOSTER FT, CRIST DM et al.: Anthro-pometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J. Acquir. Immune. Defic. Syndr. (1993) 6:245–251.
   PubMed Web of Science ®Google Scholar
• SCHAMBELAN M, MULLIGAN K, GRUNFELD C et al: Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Ann. Intern. Med. (1996) 125:873–882.
   PubMed Web of Science ®Google Scholar
• MULLIGAN K, TAI VW, SCHAMBELAN M: Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting. A clinical research center study. J. Clin. Endocrinol Metab. (1998) 83:1542–1547.
   Google Scholar
• •Evaluation of the effects of chronic rhGH treatment on components of energy balance in HIV-associated wasting.
   Google Scholar
• WATERS D, DANSKA J, HARDY K et al.: Recombinanthuman growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. (1996) 125:865–872.
   PubMed Web of Science ®Google Scholar
• IKIZLER TA, WINGARD RL, HAKIM RM: Interventions totreat malnutrition in dialysis patients: The role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone. Am. J. Kidney Dis. (1995) 26:256–265.
   PubMedGoogle Scholar
• •Review of interventions to prevent or to treat malnutrition in dialysis patients.
   Google Scholar
• ZIEGLER TR, LAZARUS JM, YOUNG LS, HAKIM R, WILMORE DW: Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J. Am. Soc. Nephrol. (1991) 2:1130–1135.
   PubMedGoogle Scholar
• •The first pilot study of anabolic responses to rhGH in haemodialysis patients.
   Google Scholar
• KOPPLE JD: The rationale for the use of growthhormone or insulin-like growth Factor I in adult patients with renal failure. Miner. Electrolyte Metab. (1992) 18:269–275.
   PubMedGoogle Scholar
• IKIZLER AT, WINGARD RL, BREYER JA, SCHULMAN G,PARKER RA, HAKIM RM: Short-term effects of recombi-nant human growth hormone in CAPD patients. Kidney Int. (1994) 46:1178–1183.
   PubMed Web of Science ®Google Scholar
• •Prospective study of rhGH therapy in CAPD patients.
   Google Scholar
• SANAKA T, SUGINO N: Improvement of malnutrition indices in adult patients with end stage renal disease by recombinant human growth hormone. Nipponlinzo Gakkai Shi (1991) 33:1153–1159.
   PubMedGoogle Scholar
• SCHULMAN G, WINGARD RL, HUTCHINSON RL, LAWRENCE P, HAKIM RM: The effects of recombinant human hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am. J. Kidney Dis. (1993) 21:527–534.
   PubMedGoogle Scholar
• •Study of the effect of combined rhGH therapy and intradia-lytic parenteral nutrition in haemodialysis patients.
   Google Scholar
• IGLESIAS P, DiEZ JJ, FERNANDEZ-REYES MJ et al.: Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study. Am. J. Kidney Dis. (1998) 32:454–463.
   PubMedGoogle Scholar
• •First randomised, controlled study of rhGH therapy in dialysis (CAPD and HD) patients.
   Google Scholar
• TAJEK JA, BRASSEL JA: Failure of anabolism in malnour-ished cancer patients receiving growth hormone. A clinical research center study. J. Clin. Endocrinol. Metab. (1995) 80:2082–2087.
   Google Scholar
• SUCHNER U, ROTHKOPF MM, STANISLAUS G, ELWYN DH, KVETAN V, ASKANAZI J: Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. Arch. Intern. Med. (1990) 150:1225–1230.
   Google Scholar
• PAPE GS, FRIEDMAN M, UNDERWOOD L, CLEMMONS DR: The effect of Gil on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest (1991) 99:1495–1500.
   PubMed Web of Science ®Google Scholar
• DOUGLAS RG, HUMBERSTONE DA, HAYSTEAD A, SHAW JHF: Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition. Br. J. Surg. (1990) 77:785–790.
   PubMed Web of Science ®Google Scholar
• VOERMAN HJ, STRACK VAN SCHIJNDEL RJ, GROENEVELD AB et al.: Effects of recombinant human growth hormone in patients with severe sepsis. Ann. Surg. (1992) 216:648–655.
   Google Scholar
• JEEVANANDAM M, ALT MR, HOLADAY NJ, PETERSEN SR: Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients. J. Parenter. Enteral Nutr. (1995) 19:137–144.
   PubMedGoogle Scholar
• KNOX J, DEMLING R, WILMORE D, SARRAF P, SANTOS A: Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J. Trauma (1995) 39:526–530.
   PubMedGoogle Scholar
• •Evaluation of safety ad efficacy of rhGH administration in a high-risk population of burned patients.
   Google Scholar
• ZIEGLER TR, YOUNG LS, MANSON JMCK, WILMORE DW: Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition. Ann. Surg. (1988) 208:6–16.
   PubMed Web of Science ®Google Scholar
• •Study of combined rhGH administration and total parenteral nutrition in postoperative patients.
   Google Scholar
• TAGLIAFERRI M, SCACCHI M, PINCELLI Al et al.: Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women. Int. J. Obes. Relat. Metab. Disord. (1998) 22:836–841.
   PubMedGoogle Scholar
• RUDMAN D, FELLER AG, NAGRAJ HS et al.: Effects of human growth hormone in men over 60 years old. New Engl. J. Merl. (1990) 323:1–6.
   PubMed Web of Science ®Google Scholar
• WAGGO H: Local treatment of ulcers in diabetic foot with human growth hormone. Lancet (1987) 1:1485.
   Google Scholar
• SALCEDO I, SERRA MB, MARQUES AP, MENDOcA M, SERRA L: Growth hormone solution applied directly to diabetic foot ulcers. Preliminary results. In: Recent Advances on Growth and Growth Hormone Therapy (Volume 2). Saggese G, Stanhope R (Eds.), Freund Publishing House Ltd., London, UK (1995):223–237.
   Google Scholar
• GENAZZANI AD, PETRAGLIA F, VOLPOGNI C et al.: Growth hormone treatment affects plasma LH pulsatile release in women with secondary amenor-rhoea. Clin. Endocrinol (1993) 39:607–611.
   PubMedGoogle Scholar
• OVENSEN PG, JORGENSEN JO, INGERSLEV J, ORSKOV H, CHRISTIANSEN JS: Growth hormone treatment of men with reduced sperm quality. Ugeskr. Laeger (1998) 160:176–180.
   PubMedGoogle Scholar
• VERHELST L, ABS R, VANDEWEDGHE M et al.: Two years of replacement therapy in adults with growth hormone deficiency. Clin. Endocrinol (1997) 47:485–494.
   PubMed Web of Science ®Google Scholar
• •Study of a large group of adult GHD patients treated with rhGH for two years.
   Google Scholar
• TAKAL J, RUOKONEN E, WEBSTER NR et al.: Increased mortality associated with growth hormone treatment in critically ill adults. New EngL J. Merl. (1999) 341:785–792.
   PubMedGoogle Scholar